Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Persistence of SARS-CoV-2 infection and viral intra- and inter-host evolution in COVID-19 hospitalized patients.

  • Authors : Pavia G; Unit of Clinical Microbiology, Department of Health Sciences, 'Magna Græcia' University Hospital, Catanzaro, Italy.; Quirino A

Subjects: COVID-19*/COVID-19*/COVID-19*/virology ; COVID-19*/COVID-19*/COVID-19*/transmission ; COVID-19*/COVID-19*/COVID-19*/epidemiology SARS-CoV-2 variants

  • Source: Journal of medical virology [J Med Virol] 2024 Jun; Vol. 96 (6), pp. e29708.Publisher: Wiley-Liss Country of Publication: United States NLM ID: 7705876 Publication Model: Print Cited Medium: Internet ISSN: 1096-9071

Record details

×
Academic Journal

A Tiny Viral Protein, SARS-CoV-2-ORF7b: Functional Molecular Mechanisms.

  • Authors : Mansueto G; Dipartimento di Scienze Mediche e Chirurgiche Avanzate, Università della Campania, L. Vanvitelli, 80138 Naples, Italy.; Fusco G

Subjects: SARS-CoV-2*/SARS-CoV-2*/SARS-CoV-2*/metabolism ; SARS-CoV-2*/SARS-CoV-2*/SARS-CoV-2*/genetics ; Protein Interaction Maps*/Protein Interaction Maps*/Protein Interaction Maps*/genetics

  • Source: Biomolecules [Biomolecules] 2024 Apr 30; Vol. 14 (5). Date of Electronic Publication: 2024 Apr 30.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101596414 Publication Model: Electronic Cited Medium: Internet ISSN: 2218-273X

Record details

×
Academic Journal

SARS-CoV-2 Omicron BA.1 Variant Infection of Human Colon Epithelial Cells.

  • Authors : Antia A; Department of Molecular Microbiology, Washington University School of Medicine in St. Louis, St. Louis, MO 63110, USA.; Alvarado DM

Subjects: SARS-CoV-2*/SARS-CoV-2*/SARS-CoV-2*/genetics ; SARS-CoV-2*/SARS-CoV-2*/SARS-CoV-2*/physiology ; SARS-CoV-2*/SARS-CoV-2*/SARS-CoV-2*/pathogenicity SARS-CoV-2 variants

  • Source: Viruses [Viruses] 2024 Apr 19; Vol. 16 (4). Date of Electronic Publication: 2024 Apr 19.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101509722 Publication Model: Electronic Cited Medium: Internet ISSN: 1999-4915

Record details

×
Academic Journal

1-L Transcription of SARS-CoV-2 Spike Protein S1 Subunit.

  • Authors : Nahalka J; Institute of Chemistry, Centre for Glycomics, Slovak Academy of Sciences, Dubravska Cesta 9, SK-84538 Bratislava, Slovakia.; Institute of Chemistry, Centre of Excellence for White-Green Biotechnology, Slovak Academy of Sciences, Trieda Andreja Hlinku 2, SK-94976 Nitra, Slovakia.

Subjects: Spike Glycoprotein, Coronavirus*/Spike Glycoprotein, Coronavirus*/Spike Glycoprotein, Coronavirus*/genetics ; Spike Glycoprotein, Coronavirus*/Spike Glycoprotein, Coronavirus*/Spike Glycoprotein, Coronavirus*/metabolism ; SARS-CoV-2*/SARS-CoV-2*/SARS-CoV-2*/genetics

  • Source: International journal of molecular sciences [Int J Mol Sci] 2024 Apr 18; Vol. 25 (8). Date of Electronic Publication: 2024 Apr 18.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067

Record details

×
Academic Journal

Collection and transportation of SARS-CoV-2 and influenza A virus diagnostic samples: Optimizing the usage of guanidine-based chaotropic salts for enhanced biosafety and viral genome preservation.

  • Authors : Komu JG; Graduate School of Animal and Veterinary Sciences and Agriculture, Obihiro University of Agriculture and Veterinary Medicine, 2-11 Inada, Obihiro, Hokkaido, 080-8555, Japan; Department of Medical Laboratory Sciences, College of Health Sciences, Jomo Kenyatta University of Agriculture and Technology, P.O. Box 62000-00200, Nairobi, Kenya. Electronic address: .

Subjects: SARS-CoV-2*/SARS-CoV-2*/SARS-CoV-2*/drug effects ; SARS-CoV-2*/SARS-CoV-2*/SARS-CoV-2*/genetics ; Influenza A virus*/Influenza A virus*/Influenza A virus*/drug effects

  • Source: Biochemical and biophysical research communications [Biochem Biophys Res Commun] 2024 Jun 30; Vol. 715, pp. 149994. Date of Electronic Publication: 2024 Apr 23.Publisher: Elsevier Country of Publication: United States NLM ID: 0372516 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Sensitive and visual detection of SARS-CoV-2 using RPA-Cas12a one-step assay with ssDNA-modified crRNA.

  • Authors : Zeng Q; Center for Medical Genetics & Hunan Key Laboratory of Medical Genetics, School of Life Sciences, Central South University, Changsha, 410078, China.; Zhou M

Subjects: SARS-CoV-2*/SARS-CoV-2*/SARS-CoV-2*/genetics ; SARS-CoV-2*/SARS-CoV-2*/SARS-CoV-2*/isolation & purification ; DNA, Single-Stranded*/DNA, Single-Stranded*/DNA, Single-Stranded*/chemistry

  • Source: Analytica chimica acta [Anal Chim Acta] 2024 Jun 22; Vol. 1309, pp. 342693. Date of Electronic Publication: 2024 May 05.Publisher: Elsevier Country of Publication: Netherlands NLM ID: 0370534 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Predicting human and viral protein variants affecting COVID-19 susceptibility and repurposing therapeutics.

  • Authors : Waman VP; Institute of Structural and Molecular Biology, University College London, London, WC1E 6BT, UK.; Ashford P

Subjects: SARS-CoV-2*/SARS-CoV-2*/SARS-CoV-2*/genetics ; SARS-CoV-2*/SARS-CoV-2*/SARS-CoV-2*/immunology ; COVID-19*/COVID-19*/COVID-19*/genetics SARS-CoV-2 variants

  • Source: Scientific reports [Sci Rep] 2024 Jun 20; Vol. 14 (1), pp. 14208. Date of Electronic Publication: 2024 Jun 20.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

A SARS-CoV-2 recombinant spike protein vaccine (S-268019-b) for COVID-19 prevention during the Omicron-dominant period: A phase 3, randomised, placebo-controlled clinical trial.

  • Authors : Dinh Thiem V; Centre for Clinical Trials, National Institute of Hygiene and Epidemiology, Ha Noi, Viet Nam.; Van Anh PT

Subjects: COVID-19 Vaccines*/COVID-19 Vaccines*/COVID-19 Vaccines*/immunology ; COVID-19 Vaccines*/COVID-19 Vaccines*/COVID-19 Vaccines*/administration & dosage ; COVID-19 Vaccines*/COVID-19 Vaccines*/COVID-19 Vaccines*/adverse effects SARS-CoV-2 variants

  • Source: Vaccine [Vaccine] 2024 Jun 20; Vol. 42 (17), pp. 3699-3709. Date of Electronic Publication: 2024 May 10.Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 8406899 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Estimation of SARS-CoV-2 fitness gains from genomic surveillance data without prior lineage classification.

  • Authors : Donker T; Institute for Infection Prevention and Control, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg im Breisgau 79106, Germany.; Papathanassopoulos A

Subjects: COVID-19*/COVID-19*/COVID-19*/virology ; COVID-19*/COVID-19*/COVID-19*/epidemiology ; COVID-19*/COVID-19*/COVID-19*/genetics SARS-CoV-2 variants

  • Source: Proceedings of the National Academy of Sciences of the United States of America [Proc Natl Acad Sci U S A] 2024 Jun 18; Vol. 121 (25), pp. e2314262121. Date of Electronic Publication: Publisher: National Academy of Sciences Country of Publication: United States NLM ID: 7505876 Publication Model: Print-Electronic Cited Medium: Internet

Record details

×
Academic Journal

Computational investigation of the inhibitory interaction of IRF3 and SARS-CoV-2 accessory protein ORF3b.

  • Authors : Bai G; Engineering Research Center of Cell & Therapeutic Antibody (MOE), School of Pharmacy, Shanghai Jiao Tong University, Shanghai, 200240, China.; Zeng X

Subjects: Interferon Regulatory Factor-3*/Interferon Regulatory Factor-3*/Interferon Regulatory Factor-3*/metabolism ; Interferon Regulatory Factor-3*/Interferon Regulatory Factor-3*/Interferon Regulatory Factor-3*/chemistry ; SARS-CoV-2*/SARS-CoV-2*/SARS-CoV-2*/metabolism

  • Source: Biochemical and biophysical research communications [Biochem Biophys Res Commun] 2024 Jun 18; Vol. 712-713, pp. 149945. Date of Electronic Publication: 2024 Apr 16.Publisher: Elsevier Country of Publication: United States NLM ID: 0372516 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
  • 1-10 of  297,194 results for ""SARS-CoV-2""